Analyst Conference Summaries

Biotechnology Investor Aids

Inovio Pharmaceuticals
INO

conference date: March 6, 2024 @ 1:30 PM Pacific Time

Inovio: Hold for Future DNA Plasmid Therapy Progress [January 10, 2023, Seeking Alpha]

Inovio Has 4 Sources Of Potential Value [June 2, 2021, Seeking Alpha]

Inovio VGX-3100 HPV Data Adds To Conviction [March 24, 2021 at Seeking Alpha]

more articles below

Analyst Call Notes by William P. Meyers
2024
Inovio
Q4 2023
     
March 6, 2024      
2023
Inovio
Q4 2022
Inovio
Q1 2023
Inovio
Q2 2023
Inovio
Q3 2023
March 1, 2023 May 10, 2023 Aug. 9, 2023 Nov. 9, 2023
2022
Inovio
Q4 2021
Inovio
Q1 2022
Inovio
Q2 2022
Inovio
Q3 2022
March 1, 2022 May 10, 2022 Aug. 9, 2022 Nov. 8, 2022
2021
Inovio
Q4 2020
Inovio
Q1 2021
Inovio
Q2 2021
Inovio
Q3 2021
March 1, 2021 May 10, 2021 Aug. 9, 2021 Nov. 9, 2021
2020
Inovio
Q4 2019
Inovio
Q1 2020
Inovio
Q2 2020
Inovio
Q3 2020
March 12, 2020 May 11, 2020 Aug. 10, 2020 Nov. 9, 2020
2019
Inovio
Q4 2018
Inovio
Q1 2019
Inovio
Q2 2019
Inovio
Q3 2019
March 12, 2019 May 9, 2019 August 8, 2019 Nov. 12, 1029
2018
March 14, 2018
May 9, 2018
August 7, 2018
Nov. 8, 2018
2017
03/15/2017
May 10, 2017
August 8, 2017
Nov. 8, 2017
2016
03/09/2016
05/09/2016
08/08/2016
11/09/2016
2015
03/16/2014
 05/11/2015
08/10/2015
11/09/2015
2014
03/17/2014
05/12/2014
08/11/2014
11/10/2014
2013
03/18/2013
05/10/2013
08/09/2013
11/12/2013
2012
03/15/2012
05/09/2012 
08/09/2012 
11/07/2012 

Inovio: Accumulate For The HPV And Brain Cancer Therapies [November 19, 2020 at Seeking Alpha]

Inovio's Wild Ride and Real Value [March 24, 2020 at Seeking Alpha]

Inovio's dBiTEs Technology Data Adds To Buy Conviction [April 23, 2019 at Seeking Alpha]

Inovio Pharmaceuticals: Roth Capital $13 Target Evaluated [December 30, 2019 at Seeking Alpha]

Inovio: Time To Think About 2020 [July 11, 2018 at Seeking Alpha]

Why Inovio Surged 13% This Week [May 19, 2017 @ Seeking Alpha]

Inovio's Zika Vaccine is not its Most Attractive Asset [March 24, 2016 @ Seeking Alpha]

Inovio's dMAb Technology [June 17, 2015 @ Seeking Alpha]

Cramer Interviews Inovio CEO Joseph Kim [June 8, 2017 @ youtube]

Zika Vaccine First Patient Dosed [Inovio release July 26, 2016]

MedImmune Licenses Inovio HPV DNA Vaccine [Inovio release August 10, 2015]
Will Inovio's Deal With Roche Lead To A Cancer Blockbuster? [August 15, 2014 @ SA]
Inovio DNA-Based Monoclonal Antibody for Dengue Positive Preclinical Results [Inovio press releae July 29, 2015]
Inovio Gets Positive HPV Therapy Results [July 23, 2014 at Seeking Alpha]
Inovio's Price Spike and the Future of DNA Vaccines [August 17, 2013]
Inovio Pharmaceuticals' H7N9 Vaccine Protects 100% Animals in Study [July 8, 2013]
Sorting Out Inovio Claims [June 12, 2013]
Inovio's Promising Vaccine Data [December 17, 2012]
Inovio Prospects [June 18, 2012]
I buy Inovio [May 21, 2012]

Inovio Pharmaceuticals (INO) is a development-stage biotechnology company specializing in DNA-based vaccine delivery.

Inovio web site
Inovio investor relations page


OpenIcon Analyst Conference Summaries Main Page

 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BLRX
 BLUE
 BMY
 CLDX
 CDTX
 FATE
 GILD
 GLYC
 ILMN
 INCY
 INO
 IONS
 ISRG
 MCHP
 MRNA
 PLX
 REGN
 RNA
 SAGE
 SANA
 SGEN
 SYRS
 TSVT
 VRTX
 VSTM
 WBA

     >
 

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but it is possible. Before making or terminating an investment you should always verify any factual basis of your decision.

Copyright 2024 William P. Meyers